Jordi Barquinero

Dr. Jordi Barquinero

orcid

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2019 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
PRPaula Rio
Paula Rio
SNSusana Navarro
Susana Navarro
WWWei Wang
Wei Wang
RSRebeca Sánchez-Domínguez
Rebeca Sánchez-Domínguez
RPRoser M. Pujol
Roser M. Pujol
JBJuan A Bueren
Juan A Bueren

15 February 1992 in Annals of Internal Medicine
Verified
Journal Article
Closed access
PDF file
EGEnrique Galve
Enrique Galve
JOJosep Ordi
Josep Ordi
JBJordi Barquinero
Jordi Barquinero
AEArturo Evangelista
Arturo Evangelista
MVMiquel Vilardell
Miquel Vilardell
JSJ. Soler-Soler
J. Soler-Soler
To determine the prevalence of cardiac valvular involvement in patients with the primary antiphospholipid syndrome. Cross-sectional study with evaluation of case patients and control patients by Doppler echocardiography. The mean follow-up for case patients was 22 months. University-based tertiary medical center. Twenty-eight consecutive patients who were diagnosed with the primary antiphospholipid syndrome during a 10-year period; 28 age- and sex-matched healthy controls. Ten patients (36%; 95% Cl, 19% to 56%) with the primary antiphospholipid syndrome had cardiac valvular involvement: Four patients had mitral valve involvement; four patients, aortic valve involvement; and two patients, both mitral and aortic valvular involvement; no patients had tricuspid or pulmonary valve disease. Eight of 10 patients had a regurgitant murmur. None of the control patients had valvular disease. The mean mitral valve thickness in patients with mitral valve involvement was 7.0 +/- 1.6 mm, compared with 2.7 +/- 0.8 mm in patients with normal valves and 3.2 +/- 0.9 mm in the control group. The mean aortic valve thickness in patients with aortic valve involvement was 3.8 +/- 0.5 mm compared with 1.4 +/- 0.3 mm in patients with normal valves and 1.4 +/- 0.5 mm in the control group. Stenotic lesions were not found. Regurgitation was severe in two patients (one required surgery), moderate in three patients, and mild in three patients. Valvular involvement is frequently found in patients with the primary antiphospholipid syndrome. The lesions are left-sided, causing regurgitation that may be clinically important.

1 November 1989
Verified
Journal Article
Closed access
RAR A Asherson
R A Asherson
MKM A Khamashta
M A Khamashta
JOJ Ordi-Ros
J Ordi-Ros
RDR H Derksen
R H Derksen
SMS J Machin
S J Machin
GHG R Hughes
G R Hughes

29 September 2004 in Gene Therapy
Verified
Journal Article
Closed access
JBJordi Barquinero
Jordi Barquinero
HAHerena Eixarch Ahufinger
Herena Eixarch Ahufinger
MPM Pérez-Melgosa
M Pérez-Melgosa

1 May 2014 in Molecular Therapy
Verified
Journal Article
Open access
JTJavier Torres-Torronteras
Javier Torres-Torronteras
CVCarlo Viscomi
Carlo Viscomi
Raquel Cabrera-PerezRaquel Cabrera-Perez
Raquel Cabrera-Perez
YCYolanda Camara
Yolanda Camara
IMIvano Di Meo
Ivano Di Meo
RMRamon Marti
Ramon Marti
Nature - the world's best science and medicine on your desktop

31 March 2011 in Gene Therapy
Verified
Journal Article
Closed access
PDF file
JTJavier Torres-Torronteras
Javier Torres-Torronteras
AGA Gómez
A Gómez
HAHerena Eixarch Ahufinger
Herena Eixarch Ahufinger
LPL Palenzuela
L Palenzuela
GPG Pizzorno
G Pizzorno
RMRamon Marti
Ramon Marti